National Transplant Organisation

In 2024, a team of researchers in China transplanted a pig's liver for the first time, with six genes modified to prevent rejection, into a person who was brain dead. After 10 days, they evaluated the condition of the organ and the recipient. According to the authors, who are now publishing the work in the journal Nature, the results suggest that genetically modified pig livers can survive and function in humans, which could serve as a bridge therapy for patients with liver failure who are waiting for human donors.

Patients receiving organ transplants often need to be treated with long-term immunosuppressants to reduce the likelihood of rejection, which has numerous side effects. An international team has shown in crab macaque monkeys that, in the case of heart transplantation, the use of these drugs could be avoided if combined with a kidney transplant from the same donor. The results are published in the journal Science Translational Medicine. 

Japanese scientists have developed tiny liver organoids from stem cells that, transplanted into mice, integrate with the original organ and help repair fibrotic lesions. This scar-like tissue damage is common to many liver diseases, such as fatty liver disease and cirrhosis. According to the authors, who publish their results in the journal Science Translational Medicine, such organoids could offer an alternative to liver transplants in the future.

Currently, when an organ transplant is performed, the patient has to take immunosuppressive drugs to prevent his or her system from rejecting the new organ. These drugs must be taken for life and have numerous side effects. In a phase 1 clinical trial, researchers gave patients receiving a liver transplant regulatory dendritic cells derived from the original donor, with the hypothesis that these cells could 'teach' the recipient's immune system to tolerate the new organ. The research, published in Science Translational Medicine, suggests that this treatment could reduce or even eliminate the need for long-term use of immunosuppressants.

Scientists have successfully developed pig embryos whose kidneys contain 50-60% human cells. Gestation was terminated at 25-28 days, and the organ structure was normal. According to the press release accompanying the article, "this is the first time that a solid humanised organ has been grown inside another species, although previous studies have used similar methods to generate human tissues". The results are published in the journal Cell Stem Cell. 

Researchers have developed a system capable of restoring some molecular and cellular functions and preserving tissues in pigs when initiated one hour after death. The study is published today in the journal Nature.